CK2α phosphorylates DBC1 and is involved in the progression of gastric carcinoma and predicts poor survival of gastric carcinoma patients.
about
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinomaDBC1 functions as a tumor suppressor by regulating p53 stabilityThe protein kinase 2 inhibitor tetrabromobenzotriazole protects against renal ischemia reperfusion injury.CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.DBC1/CCAR2 is involved in the stabilization of androgen receptor and the progression of osteosarcomaIncreased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma.Role of Eukaryotic Initiation Factors during Cellular Stress and Cancer ProgressionCK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant MelanomaMolecular characterization of clear cell renal cell carcinoma identifies CSNK2A1, SPP1 and DEFB1 as promising novel prognostic markers.Cancer-type dependent expression of CK2 transcripts.CCAR2 negatively regulates IL-8 production in cervical cancer cells.
P2860
Q35105594-3B0384D3-5186-4363-86A4-5825AADFEB6DQ35152261-6B2AC19D-BDBD-4753-8AB6-D8B82C03575DQ36109789-D3475CAA-E79D-46E4-980D-46FF3185E2B1Q36263671-4B5444BE-84FA-4DF9-A087-E45C1DDDB1FFQ36273633-D5ACA3FF-1401-4BA3-B974-3CEAA1B8EC74Q36326939-19898D8B-AD59-4BA6-AE72-AEEE2B3B1E92Q36544222-7C51D511-1ED5-4313-9D54-C7FEE5861426Q37548069-3F12FE24-2A06-47F0-811E-586B5E1A9E0DQ37641686-0E5FF203-8900-4E0C-A299-7E9086D90168Q38492153-F4CE5A0E-6902-444D-9305-FD4CB7340D65Q38768362-231D8FBB-991E-4EA6-A598-C251AE49174CQ39997736-632757A4-6C70-4750-8866-88176AA30EB9Q47114281-F783A71E-598A-41FB-83D5-8AAC013397F8Q49576424-E09EAA24-2906-480C-B397-FC7444FFF42E
P2860
CK2α phosphorylates DBC1 and is involved in the progression of gastric carcinoma and predicts poor survival of gastric carcinoma patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
CK2α phosphorylates DBC1 and i ...... of gastric carcinoma patients.
@en
type
label
CK2α phosphorylates DBC1 and i ...... of gastric carcinoma patients.
@en
prefLabel
CK2α phosphorylates DBC1 and i ...... of gastric carcinoma patients.
@en
P2093
P2860
P356
P1476
CK2α phosphorylates DBC1 and i ...... of gastric carcinoma patients.
@en
P2093
Byung-Hyun Park
Chan Young Kim
Ho Sung Park
Hun Ku Lee
Jun Sang Bae
Karl G Sylvester
Keun Sang Kwon
Kyoung Min Kim
Kyu Yun Jang
P2860
P304
P356
10.1002/IJC.29043
P577
2014-07-01T00:00:00Z